Genic Co., Ltd.
Research Genic Co., Ltd. (123330.KQ) on Bullrun: market cap KRW 147.26B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker123330.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyKRW
- Market capKRW 147.26B
- Financial periodQ2 2026
- RevenueKRW 49.21B
- Net incomeKRW 11.21B
- Free cash flow-KRW 4.48B
- Gross margin25.3%
Valuation Snapshot
latest market cap is KRW 147.26B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 147.26B | n/a | n/a | n/a |
Dividend history
About Genic Co., Ltd.
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Genic Co., Ltd.'s market cap?
Genic Co., Ltd.'s market capitalization is KRW 147.26B.
What does Genic Co., Ltd. do?
Genic Co., Ltd. researches, develops, manufactures, and sells cosmetics and pharmaceuticals in South Korea and internationally. The company provides hydrogel masks, sheet masks, cream wrapping masks, mud masks, and bio cellulose masks; nose patch, eye patch, body patch, eye gel, lifting patch, and outdoor patches; cleanser, toner, lotion, serum, cream, sunscreen, and cleansing/soothing/oil pad; and shampoo and tonic. It offers its products under the CELEDERMA, CELEDERMA daily, and Excuse my Frank brands. Genic Co., Ltd. was founded in 2001 and is headquartered in Seongnam-si, South Korea.